MedPath

Digital Health Interventions for Obsessive Compulsive Disorder (OCD)

Not Applicable
Completed
Conditions
Obsessive-Compulsive Disorder
Interventions
Device: Perspectives OCD
Device: The Health and Well-Being Program
Registration Number
NCT04136626
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The investigators are testing two digital health interventions for obsessive compulsive disorder (OCD). The investigators hope that these digital health programs will increase access to treatment for OCD.

Detailed Description

The primary aims of this study are to test the feasibility, acceptability, and efficacy of two digital health interventions for adults with OCD recruited nationally. Eligible subjects (N=120) will be randomly assigned (50/50 chance) to 12 weeks of app-based CBT on their personal Smartphone or 12 weeks of web-based health and well-being education in addition to completing clinical assessments and questionnaires from home. All participants will have access to a coach to help guide them through their assigned program. Total participation time for the study is approximately 6 months, and all study appointments (5 total) occur over secure phone or video conference call.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • At least 18 years of age
  • Current diagnosis of primary obsessive compulsive disorder (OCD), based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), Mini International Neuropsychiatric Interview (MINI)
  • Currently living in the United States
Exclusion Criteria
  • Psychotropic medication changes within 2 months prior to enrollment (Participants taking psychotropic medication must have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period)
  • Past participation in ≥4 sessions of cognitive behavioral therapy (CBT) for OCD
  • Past use of a CBT for OCD app
  • Current severe substance use disorder
  • Lifetime bipolar disorder or psychosis
  • Acute, active suicidal ideation as indicated by clinical judgment and/or a score ≥2 on the suicidal ideation subscale of the Columbia Suicide Severity Rating Scale (C-SSRS).
  • Current severe comorbid major depression, as indicated by clinical judgment and/or a Quick Inventory of Depressive Symptomatology, self-report version (QIDS-SR), total score ≥ 21
  • Current post-traumatic stress disorder (PTSD)
  • Concurrent psychological treatment
  • Does not own a supported mobile smartphone with a data plan
  • Lack of technology literacy that would interfere with ability to engage with smartphone treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Perspectives OCDPerspectives OCD12 week Smartphone-delivered CBT for OCD.
The Health and Well-Being ProgramThe Health and Well-Being Program12 week health and well-being education
Primary Outcome Measures
NameTimeMethod
Difference in OCD Symptom Severity at the End of Week 12Baseline (week 0), mid-treatment (week 6), end-of-treatment (week 12)

Symptom severity for OCD was measured with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the gold-standard, semi-structured clinician-administered assessment of OCD severity. It contains 10 items ranging from 0 to 4, which are summed to generate a total score (range 0 to 40). Higher scores indicate more severe OCD symptoms.

Secondary Outcome Measures
NameTimeMethod
Difference in Depression at the End of Week 12Baseline (week 0), mid-treatment (week 6), end-of-treatment (week 12)

The Quick Inventory of Depressive Symptomatology (Self-report; QIDS-SR) is a self-report measure of depressive symptoms consisting of 16 scale items with responses ranging from 0 to 3, including one suicide item (item #12). Total scores range from 0 to 27 with higher scores indicating greater depression severity. The measure is a well-validated, sensitive measure of symptom severity in depression.

Difference in Functional Impairment at the End of Week 12Week 0, Week 6, and Week 12

Functional impairment was assessed using the Work and Social Adjustment Scale (WSAS). This scale uses a Likert scale from 0 (not at all) to 10 (extremely) to assess impairment in a person's ability to function in terms of work, home management, leisure activities. Total scores total range from 0-40, where higher scores indicate greater impairment.

Difference in Quality of Life at the End of Week 12Week 0, Week 6, and Week 12

The Quality of Life Enjoyment and Satisfaction Questionnaire Short Form (Q-LES-Q-SF) is a self-report measure of subjective quality of life, containing Likert items ranging from 1 (Very Poor) to 5 (Very Good). Total scores are presented as a percentage of the maximum value (i.e., ranging from 0 to 100), with higher scores indicating greater quality of life).

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath